公司资料
Inovio Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- INO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.24 USD (0.00%)
收盘价
最后更新: 2026年9月21日
99.6M USD
市值
股价为何变动
截至 2026年9月21日，INO 股价变化不大，收于 $1.24。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Inovio Pharmaceuticals is a DNA-vaccine and immunotherapy company focused on infectious disease and oncology programs. Its business has long been tied to nucleic-acid delivery and immune activation.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Inovio sits in specialty biotechnology.
商业模式特征
The company depends on clinical proof, platform validation, and the ability to turn DNA-based science into durable value.
生物医药行业定位
Inovio is a high-uncertainty platform biotech whose stock is sensitive to progress and credibility.
未来催化剂
- Inovio’s catalysts are INO-3107 and the rest of its DNA-vaccine platform, where the next clinical or regulatory update can either revive or weaken the story. Investors will care about whether the company can keep demonstrating that electroporation-based delivery still matters.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。